Erisyon has developed a groundbreaking technology known as Fluorosequencing, which represents the world's first single-molecule protein sequencer. This innovative approach significantly enhances the field of proteomics by offering ultimate sensitivity, massively parallel architecture, and absolute quantification of proteins. Fluorosequencing allows for the detection of extremely low sample sizes, making it particularly useful for applications such as liquid biopsies and the analysis of tumor biopsies. By enabling researchers to conduct billions of simultaneous experiments, this technology empowers scientists to ask more precise questions and tackle difficult-to-treat diseases across various fields, including neurology, oncology, and infectious diseases.

The Fluorosequencing method is distinguished by its ability to accurately identify and quantify proteins with unprecedented sensitivity—reportedly one million times more sensitive than traditional mass spectrometry. This technology not only facilitates the detection of proteins in highly heterogeneous samples but also allows for the characterization of proteins without the need for external calibrants. By employing a unique process that involves fluorescent labeling and imaging, Fluorosequencing can catalog proteins from single cells and identify peptides in complex biological mixtures. Overall, Erisyon's Fluorosequencing technology promises to transform biological research and clinical applications, leading to earlier disease detection and improved therapeutic strategies.

United States

Erisyon is transforming the field of proteomics with the world's first single molecule protein sequencer. With unprecedented sensitivity and scalability for proteomics, Erisyon enables new applications across the Life Sciences

Erisyon has emerged from the University of Texas at Austin to commercialize the world's first single molecule protein sequencer. Inheriting work developed over the course of the past decade at UT's Center for Systems and Synthetic Biology, Erisyon was founded by a group of technologists and entrepreneurs with the ambition to usher in new discoveries that make the world healthier, safer, and more abundant.

Erisyon

Company Details